Insider Transactions in Q3 2021 at Altimmune, Inc. (ALT)
Insider Transaction List (Q3 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 30
2021
|
Vipin K Garg President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,007
-1.02%
|
$33,077
$11.31 P/Share
|
Aug 30
2021
|
Vipin K Garg President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,008
-1.01%
|
$42,112
$14.09 P/Share
|
Jul 31
2021
|
M Scot Roberts Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,750
+13.1%
|
$12,250
$7.71 P/Share
|
Jul 31
2021
|
William Michael Brown Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
803
+4.33%
|
$5,621
$7.71 P/Share
|
Jul 31
2021
|
Matthew Scott Harris Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
725
+11.18%
|
$5,075
$7.71 P/Share
|
Jul 30
2021
|
Vipin K Garg President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,007
-1.0%
|
$27,063
$9.07 P/Share
|